{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:39:34Z","timestamp":1790105974406,"version":"4.0.1"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0218330","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T17:44:35Z","timestamp":1560447875000},"page":"e0218330","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Development of novel monoclonal antibodies with specific binding affinity for denatured human CD26 in formalin-fixed paraffin-embedded and decalcified specimens"],"prefix":"10.1371","volume":"14","author":[{"given":"Ryo","family":"Hatano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Madokoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruna","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Komiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam H.","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ohnuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3140-3596","authenticated-orcid":true,"given":"Chikao","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,6,13]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4049\/jimmunol.133.3.1250","article-title":"Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody","volume":"133","author":"DA Fox","year":"1984","journal-title":"J Immunol"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4049\/jimmunol.149.2.481","article-title":"Cloning and functional expression of the T cell activation antigen CD26","volume":"149","author":"T Tanaka","year":"1992","journal-title":"J Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-065X.1998.tb01571.x","article-title":"The structure and function of CD26 in the T-cell immune response","volume":"161","author":"C Morimoto","year":"1998","journal-title":"Immunol Rev"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.it.2008.02.010","article-title":"Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function","volume":"29","author":"K Ohnuma","year":"2008","journal-title":"Trends Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.2741\/2844","article-title":"Role of CD26\/dipeptidyl peptidase IV in human T cell activation and function","volume":"13","author":"K Ohnuma","year":"2008","journal-title":"Front Biosci"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0167-5699(99)01486-3","article-title":"CD26, let it cut or cut it down","volume":"20","author":"I De Meester","year":"1999","journal-title":"Immunol Today"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.4049\/jimmunol.143.11.3430","article-title":"1F7, a novel cell surface molecule, involved in helper function of CD4 cells","volume":"143","author":"C Morimoto","year":"1989","journal-title":"J Immunol"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/imm.12028","article-title":"CD26-mediated co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine production","volume":"138","author":"R Hatano","year":"2013","journal-title":"Immunology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.2741\/2787","article-title":"The role of CD26\/dipeptidyl peptidase IV in cancer","volume":"13","author":"PA Havre","year":"2008","journal-title":"Front Biosci"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"e98582","DOI":"10.1371\/journal.pone.0098582","article-title":"Prognostic significance of CD26 in patients with colorectal cancer","volume":"9","author":"CS Lam","year":"2014","journal-title":"PLoS One"},{"issue":"25","key":"ref11","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1200\/JCO.2007.14.2331","article-title":"Distinct gene expression-defined classes of gastrointestinal stromal tumor","volume":"26","author":"U Yamaguchi","year":"2008","journal-title":"J Clin Oncol"},{"issue":"7","key":"ref12","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/ijc.29172","article-title":"A three-gene panel that distinguishes benign from malignant thyroid nodules","volume":"136","author":"B Zheng","year":"2015","journal-title":"Int J Cancer"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.18632\/oncotarget.13820","article-title":"DPP4\/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness","volume":"8","author":"PI Liang","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"ref14","first-page":"647","article-title":"Expression of CD26 and CXCR4 in prostate carcinoma and its relationship with clinical parameters","volume":"18","author":"Z Lu","year":"2013","journal-title":"J Res Med Sci"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bbrc.2010.12.054","article-title":"Identification of cancer stem cell markers in human malignant mesothelioma cells","volume":"404","author":"FI Ghani","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbrc.2012.02.054","article-title":"Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells","volume":"419","author":"H Yamazaki","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.stem.2010.04.001","article-title":"A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer","volume":"6","author":"R Pang","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"25","key":"ref18","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2013-10-536078","article-title":"Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia","volume":"123","author":"H Herrmann","year":"2014","journal-title":"Blood"},{"issue":"7","key":"ref19","first-page":"2031","article-title":"In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299","volume":"7","author":"L Ho","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1158\/1078-0432.CCR-06-0361","article-title":"Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix","volume":"12","author":"T Inamoto","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"14","key":"ref21","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1158\/1078-0432.CCR-07-0110","article-title":"Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors","volume":"13","author":"T Inamoto","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"e86671","DOI":"10.1371\/journal.pone.0086671","article-title":"CD9 negatively regulates CD26 expression and inhibits CD26-mediated enhancement of invasive potential of malignant mesothelioma cells","volume":"9","author":"T Okamoto","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1038\/bjc.2014.151","article-title":"Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma","volume":"110","author":"J Yamamoto","year":"2014","journal-title":"Br J Cancer"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/bjc.2017.62","article-title":"First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers","volume":"116","author":"E Angevin","year":"2017","journal-title":"Br J Cancer"},{"key":"ref25","unstructured":"ClinicalTrials.gov. 2017. Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03177668?term=YS110&cond=Mesotheliomas+Pleural&rank=1\" xlink:type=\"simple\">https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03177668?term=YS110&amp;cond=Mesotheliomas+Pleural&amp;rank=1<\/ext-link>"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0161-5890(98)80013-8","article-title":"Correlation of the epitopes defined by anti-CD26 mAbs and CD26 function","volume":"35","author":"RP Dong","year":"1998","journal-title":"Mol Immunol"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"e62304","DOI":"10.1371\/journal.pone.0062304","article-title":"Nuclear localization of CD26 induced by a humanized monoclonal antibody inhibits tumor cell growth by modulating of POLR2A transcription","volume":"8","author":"K Yamada","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-11-1990","article-title":"CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesothelioma","volume":"18","author":"K Aoe","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1746-1596-9-30","article-title":"Establishment of monoclonal anti-human CD26 antibodies suitable for immunostaining of formalin-fixed tissue","volume":"9","author":"R Hatano","year":"2014","journal-title":"Diagn Pathol"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0161-5890(92)90099-J","article-title":"Biochemical characterization of CD26 (dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies","volume":"29","author":"Y Torimoto","year":"1992","journal-title":"Mol Immunol"},{"issue":"8","key":"ref31","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1073\/pnas.91.8.3082","article-title":"Enhancement of antigen-induced T-cell proliferation by soluble CD26\/dipeptidyl peptidase IV","volume":"91","author":"T Tanaka","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nprot.2016.180","article-title":"Modeling and docking of antibody structures with Rosetta","volume":"12","author":"BD Weitzner","year":"2017","journal-title":"Nat Protoc"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1002\/jbmr.2277","article-title":"Blockade of CD26 signaling inhibits human osteoclast development","volume":"29","author":"H Nishida","year":"2014","journal-title":"J Bone Miner Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0218330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T12:25:22Z","timestamp":1694953522000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0218330"}},"subtitle":[],"editor":[{"given":"Arun","family":"Rishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,6,13]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0218330","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,13]]}}}